Mechanism and Research Interest

Primary Biological Pathway: Selective Lipolysis The defining characteristic of AOD9604 is its ability to regulate fat metabolism independently of the cAMP-PKA pathway used by adrenergic agonists. It stimulates lipolysis (the breakdown of stored triglycerides into free fatty acids) and inhibits lipogenesis (the formation of new fat) in adipocytes. Research utilising the 10mg pen focuses on quantifying this effect in visceral vs. subcutaneous adipose tissue. Crucially, studies aim to demonstrate that this lipid mobilisation occurs without the hyperglycaemia or hyperinsulinaemia associated with full-length hGH administration.

Secondary Research Finding: Cartilage and Connective Tissue Repair Beyond metabolism, AOD9604 has emerged as a significant peptide in orthopaedic research. Evidence suggests it enhances the differentiation of mesenchymal stem cells into chondrocytes and promotes the synthesis of collagen and proteoglycans. The 10mg formulation is utilised in intra-articular injection models (e.g., collagenase-induced osteoarthritis in rabbits) to measure the regeneration of hyaline cartilage and the reduction of synovial inflammation.

Tertiary Research Finding: Safety and IGF-1 Independence A major hurdle in hGH research is the elevation of Insulin-Like Growth Factor 1 (IGF-1), which carries potential mitogenic risks. AOD9604 is non-mitogenic. It does not stimulate IGF-1 secretion. Researchers use the 10mg pen as a “negative control” for IGF-1 pathways, proving that observed metabolic or reparative improvements are due to direct peptide action on the target tissue rather than systemic growth factor cascades.

Long-term Genomic and Safety Observations Safety pharmacology studies regarding AOD9604 focus on its lack of antigenicity. Unlike earlier hGH fragments, the specific amino acid sequence of AOD9604 appears to avoid triggering anti-GH antibodies. Genomic studies utilising the 10mg dose monitor inflammatory markers (CRP, TNF-$\alpha$) to verify that the peptide exerts a net anti-inflammatory effect in obese models, counteracting the chronic low-grade inflammation typical of metabolic syndrome.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). We strictly control the synthesis to ensure the Tyrosine residue is correctly attached, as this modification is critical for the peptide’s resistance to rapid enzymatic degradation in plasma.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen delivery system ensures accurate volumetric dosing. This is essential for distinguishing between the lower doses required for cartilage repair and the higher systemic doses often used for metabolic studies.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The AOD9604 10mg Pen is a stable peptide fragment but requires refrigeration (2∘C to 8∘C). The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days. Researchers should note that while the Tyrosine stabilisation improves half-life, the disulfide bridge (if formed in specific conformations) or linear structure is still susceptible to thermal stress.

Shipping Stability We utilise medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to ensure the highest fidelity for metabolic assays, we recommend selecting the fastest available shipping option.

Freezing Warning Do not freeze. Freezing can cause the peptide to precipitate out of the solution. Upon thawing, the solution may become cloudy or contain invisible aggregates. In precise lipolysis assays, variable concentration can lead to erratic data regarding free fatty acid release. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The AOD9604 10mg Pen is the definitive tool for Targeted Metabolic and Orthopaedic Research. Investigating fat loss or cartilage repair using full-length hGH introduces a myriad of confounding variables (insulin resistance, organ growth, edema).

Our AOD9604 pen isolates the specific functional domain. It provides a sterile, concentration-verified source that allows researchers to attribute observed effects strictly to the 177-191 fragment’s activity, providing clean, reproducible data that separates metabolic regulation from systemic growth.

For researchers investigating related repair or metabolic pathways, we recommend examining:

• HGH Fragment 176-191 5mg: (For comparative studies on the non-tyrosine modified precursor).

• BPC-157 10mg: (For comparative studies on tendon and ligament repair mechanisms).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection (e.g., for weight loss or bodybuilding), therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.